Division of Urology

The Division of Urology offers a full range of surgical treatment options with strong emphasis on minimally invasive and robotic-assisted procedures that promote early recovery and decreased pain. State-of-the-art treatment is available for prostate, bladder and kidney cancers and disease, as well as urological trauma. The Division also has expertise in treating sexual dysfunction and male infertility, urological infections, and incontinence.

For the fifth straight year, the University of Cincinnati Division of Urology at University Hospital was listed among the top 50 urology programs in the United States by US News & World Report. It was the only local urology program to be recognized.

The faculty has significant experience in robotic-assisted approaches to radical prostatectomy and nephrectomy, pyeloplasty, ureteral re-implant, and reconstruction of the genitourinary tract. Radio-frequency ablation (RFA) and cryoablation continue to show promising results in the treatment of small renal tumors.

Cincinnati Surgery: Urology

Other procedures performed include:

• Prostate benign enlargement, BPH, prostate cancer
• Adrenal laparoscopy
• Laparoscopic pyeloplasty
• Lymph node dissection
• Partial nephrectomy
• Laparoscopic nephrectomy
• Laser prostatectomy
• Laparoscopic adrenalectomy
• Nephrectomy, partial nephrectomy
• Pyeloplasty
• Vermix ligation
• Ureteral reimplant
• Cryotherapy

Dr. Bruce Bracken is an internationally recognized leader in urologic cancer therapy using both medical and surgical therapy. Dr. Hamidinia offers expert medical and microsurgical treatment of male infertility, sexual dysfunction, and vasectomy reversal.

The Division of Urology’s residency training program received renewed accreditation from the Residency Review Committee in March 2006, with no deficiencies. The Division also offers a Pediatric Urology Fellowship program and a fellowship program in Endourology, Laparoscopy and Robotic Surgery.

The Division of Urology is currently involved in 12 clinical trials evaluating new therapies for prostate cancer, prostate cancer prevention, and renal cell carcinoma.

Drs. Donovan and Gaitonde received recognition from their peers in the community as two of "Cincinnati's "Top Docs" as published in Cincinnati Magazine in January 2010.